Publication | Closed Access

Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan

MedicineEgfr PathwayAnti-cancer AgentRadiation OncologyOncologyCell BiologyCancer ResearchCancer Growth